January 31, 2012
FRANKLIN LAKES, N.J. -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 45 cents per common share, payable on March 30, 2012 to holders of record on March 9, 2012. The indicated annual dividend rate is $1.80 per share. About BD BD is a leading [...]
Roche Diagnostics Announces Dan Zabrowski as New Head of Roche Applied Science
January 31, 2012
Penzberg, Germany - Dan Zabrowski is Head of Roche Applied Science in the Diagnostics Division, located in Penzberg, Germany. He succeeds Paul Brown who has led Roche Applied Science since September 2011. Dan Zabrowski will report to Daniel O’Day, COO Roche Diagnostics. Dan recently served as Global Head of Roche Partnering and was a member [...]
DNA2.0 Introduces Protein Variant Libraries
January 31, 2012
Menlo Park, California, DNA2.0 today introduced a complete line of Protein Variant Libraries designed to help researchers better engineer proteins. Four key library options —Alanine Scanning, Single Site Saturation, Combinatorial Site and Antibody—are suited for the most common methods of protein engineering, although DNA2.0 can produce additional libraries, such as Modular, Truncation or Random Mutagenesis [...]
Datacolor Unveils 45G Reference-grade Handheld Spectrophotometer
January 31, 2012
LAWRENCEVILLE, N.J.--Datacolor®, a global leader in color management solutions, announces the availability of the Datacolor 45G, a high accuracy handheld spectrophotometer with integrated gloss measurement. Datacolor 45G excels in color appearance evaluation of painted surfaces, plastic parts, package prints, automotive parts, commercial furniture and other manufactured goods. Measurements made with the 45G capture the effect [...]
Sapio Sciences Announces Exemplar Dx LIMS for Laboratories in the Burgeoning MDx Market
January 31, 2012
BALTIMORE-- Sapio Sciences is pleased to announce the immediate availability of Exemplar Dx LIMS. This release is the result of Sapio's extensive experience in implementing LIMS at leading MDx companies. Exemplar Dx LIMS addresses MDx companies' operational needs in a single, integrated solution. The MDx Market The molecular diagnostics market is experiencing rapid growth largely [...]
January 31, 2012
Roche announced today that it has provided notice to Illumina, Inc. (NASDAQ: ILMN) that it will nominate a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and propose certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which, if adopted, would result in Roche-nominated directors [...]
Corning Launches Label-free Cellular Profiling Service for Drug Discovery
January 31, 2012
CORNING, N.Y., -- Corning Incorporated today announced its new Corning® Epic® Pharmacology service for drug discovery. The service uses Corning’s holistic assay approach to drug discovery and pathway biology to provide high-value cellular profiling in native cellular systems. The Corning Epic Pharmacology service is a key new offering from Corning’s portfolio of Epic Discovery Services, [...]
January 31, 2012
Berlin, Dr Clemens Franz leads a group of researchers at the DFG-Center for Functional Nanostructures at Karlsruhe Institute of Technology where he works on expanding the use of AFM for cell biological applications. AFM has a strong advantage over other microscopy techniques. Samples can be imaged directly without prior preparation, such as staining or fixation. [...]
Oxford Nanopore to Present DNA ‘Strand Sequencing’ Technology at AGBT Conference
January 31, 2012
Oxford Nanopore Technologies Ltd. announces that Clive G Brown, Chief Technology Officer, will present at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida, on 17th February 2012 at 11.40am (EST) / 4.40pm (GMT). The talk is titled: “Single Molecule ‘Strand’ Sequencing Using Protein Nanopores and Scalable Electronic Devices”. Oxford Nanopore [...]
Techne Corporation Releases Unaudited Second Quarter and Six Month Fiscal Year 2012 Results
January 31, 2012
MINNEAPOLIS -- Techne Corporation's (NASDAQ: TECH) financial results for the second quarter and six months ended December 31, 2011 include the following highlights: Second quarter earnings were $25.8 million or $0.70 per diluted share. Adjusted earnings for the quarter grew 5.1%, to $28.0 million or $0.76 per diluted share after adjustment for intangible asset amortization [...]
